Monday, December 23, 2024
HomeTagsNeurologists

Neurologists

U.S. Neurologists Cautiously Optimistic Following Accelerated Approval and Launch of Eisai/Biogen’s Leqembi for Early Alzheimer’s Disease, According to Spherix Global Insights

With the accelerated approval on January 6, 2023 for early Alzheimer's disease, Eisai/Biogen's Leqembi became only the second approved disease-modifying therapy (DMT) for early Alzheimer's...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics